Report of Foreign Issuer (6-k)
29 November 2018 - 10:11PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of November 201
8
.
Commission File Number: 001-36403
IKANG HEALTHCARE GROUP, INC.
(Exact name of registrant as specified in its charter)
B-6F, Shimao Tower
92A Jianguo Road
Chaoyang District, Beijing 100022
Peoples Republic of China
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F
x
Form 40-F
o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
o
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
IKANG HEALTHCARE GROUP, INC.
|
|
|
|
|
|
|
|
Date: November 29, 2018
|
|
By:
|
/s/ Yang Chen
|
|
|
Name: Yang Chen
|
|
|
Title: Chief Financial Officer
|
2
Exhibit Index
4.1
|
|
Amendment No. 5 to Rights Agreement, dated as of November 29, 2018, between iKang Healthcare Group, Inc. and American Stock Transfer & Trust Company, L.L.C., as Rights Agent.
|
|
|
|
99.1
|
|
Press release, dated November 29, 2018, issued by the Company
|
3
IKANG HEALTHCARE GROUP, INC. (NASDAQ:KANG)
Historical Stock Chart
From Apr 2024 to May 2024
IKANG HEALTHCARE GROUP, INC. (NASDAQ:KANG)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Ikang Healthcare Grp. ADS (NASDAQ): 0 recent articles
More Ikang Healthcare Group, Inc. News Articles